This latest analysis also predicted that in 2020 in the USA, 191,930 new males would suffer from PCa, accounting for 21% of all new cancer cases and showing an increasing trend compared to less than 20% before 2018; about 33,330 diagnosed patients eventually die for it, with the mortality rate second only to lung cancer among men [ 2 ].
← all excerpts
Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) gene polymorphism with susceptibility to prostate cancer: an updated meta-analysis.
1
—
—